$18.00
Manufacturer: South Korea
Antidiabetic drugs. Combination of oral hypoglycemic drugs. Metformin and sulfonamides
- if monotherapy with glimepiride or metformin does not provide an adequate level of glycemic control;
- in case of replacement of combined therapy with glimepiride and metformin.
Description
Amaryl M 2 mg/500 mg tablets is a medicine for the treatment of diabetes. It is intended to reduce the concentration of sugar in the blood, that is, it belongs to hypoglycemic drugs. Amaryl M tablets are a combined agent with glimepiride and metformin.
Glimepiride affects the pancreas, normalizes the production of insulin and its delivery to the blood. Glimepiride helps calcium from the blood enter the tissue cells, inhibits the formation of atherosclerotic plaques on the vascular walls. Metformin lowers blood sugar by improving blood circulation in the liver and stimulating the transformation of glucose into glycogen.
- if monotherapy with glimepiride or metformin does not provide an adequate level of glycemic control;
- in case of replacement of combined therapy with glimepiride and metformin.
Contraindications Amaryl M
Amaryl M, like Amaryl, is contraindicated in insulin-dependent diabetes mellitus, such diabetic complications as diabetic coma, ketoacidosis, liver and kidney pathologies, lactation and pregnancy, and intolerance to the components of the drug.
Recent Reviews